Practical Lipid Management
Home > Medicine & Health Science textbooks > Clinical and internal medicine > Practical Lipid Management: Concepts and Controversies
52%
Practical Lipid Management: Concepts and Controversies

Practical Lipid Management: Concepts and Controversies


     0     
5
4
3
2
1



Out of Stock


Notify me when this book is in stock
X
About the Book

Lipid management is a key part of medical practice, affecting the prevention and treatment of several diseases, including diabetes, cardiovascular disease and stroke. A practical text on the clinical management of dyslipidemias, Practical Lipid Management balances conceptual development and pathophysiology with a straightforward approach to the identification and treatment of abnormalities in lipid metabolism. The book explores the role of novel risk markers in clinical practice, summarizes the current guidelines for lipid management, and offers a critical and systematic approach to interpreting the results of clinical trials. A feature of the book is a set of sidebars which explore current controversies and unanswered questions in clinical lipidology. The treatment of specific dyslipidemias is illustrated with case studies. Treatment algorithms are also provided. Practical Lipid Management: details the relationship between specific lipids, lipoproteins and cardiovascular disease, provides guidance on the etiology and diagnosis of lipid abnormalities, summarizes current understanding of atherogenesis, and reviews the evidence base for the use of therapeutic lifestyle change and specific lipid-lowering medications to reduce morbidity and mortality from cardiovascular disease. Practical Lipid Management provides a concise summary of best practice according to various international guidelines, making it a useful tool for all primary care physicians and others involved in the management of diseases such as diabetes, cardiovascular disease and stroke. It will serve as an evidence-based, rapid, and valuable resource for family physicians, internists, nurse practitioners, physician assistants, cardiologists, endocrinologists and allied health professionals involved in the care of patients with lipid disorders.

Table of Contents:
Foreword. Preface. Acknowledgements. Chapter 1 Epidemiology of Lipids, Lipid Management and Risk for Coronary Heart Disease: An Overview. 1.1 Early History of Cardiovascular Epidemiology. 1.2 Lipid Risk Factors are Central to Efforts at CHD Prevention. 1.3 LDL-C and CHD Risk. 1.4 LDL-C Lowering and CHD Risk Reduction. 1.5 Other Atherogenic Lipoproteins: Atherogenic Remnants. 1.6 HDL-C and CHD Risk. 1.7 Trends in Lipids and Lipid Management in the USA. 1.8 The National Cholesterol Education Program Evaluation Project Using Novel E-Technology (NEPTUNE) II Survey. Controversy: Should a Measure of Atherogenic Lipoprotein Particle Number be used in Risk Assessment And/Or to Evaluate the Response to Lipid Therapy? Chapter 2 Vascular Biology and Atherogenesis. 2.1 Introduction. 2.2 Arterial Structure. 2.3 Endothelial Cell Function and Dysfunction. 2.4 The Role of Monocytes and Lymphocytes. 2.5 Atheromatous Plaques. Chapter 3 Detection, Evaluation, and Treatment Goals for Lipid Disorders in Adults. 3.1 Matching Aggressiveness of Treatment to Absolute Risk. 3.2 Screening for Dyslipidemias. 3.3 Risk Stratification. 3.4 Steps in the Risk Stratification Process – Major Risk Categories. 3.5 Tips for Calculating the Framingham Risk Score. 3.6 Subcategories for Consideration ofMore Aggressive Optional Treatment Goals. 3.7 Very High Risk Patients, Optional LDL-C Goal <70 mg dl−1 40. 3.8 Moderately High Risk Patients, OPTIONAL LDL-C Goal <100 mg dl−1 40. 3.9 Treatment Goals for Patients with Elevated Triglycerides. 3.10 Triglycerides and HDL-C as Targets for Therapy. Controversy: Should Treatment Guidelines Include Targets for the Total/HDL Cholesterol Ratio? Chapter 4 Therapeutic Lifestyle Changes in the Management of Lipid Disorders and the Metabolic Syndrome. 4.1 Nature and Nurture in the Development of CHD Risk Factors. 4.2 Lifestyle Factors as Determinants of CHD Risk in Populations. 4.3 Within Country Variations in Lifestyle and CHD Risk. 4.4 The Metabolic Syndrome. 4.5 Therapeutic Lifestyle Changes. 4.6 The TLC Diet. 4.7 Dietary Adjuncts: Viscous Fibers and Plant Sterol/Stanol Products. 4.8 Physical Activity and Weight Reduction. 4.9 Smoking Cessation. 4.10 Importance of Allied Health Professionals. Chapter 5 Management of Elevated Low-Density Lipoprotein Cholesterol. 5.1 Relationship between LDL-C and Risk for Cardiovascular Events. 5.2 Clinical Trial Support for Very Aggressive LDL-C Reduction for Those at Highest Risk. 5.3 Genetic Disorders Associated with Elevated LDL-C. 5.4 Atherogenic Impact of LDL-C. 5.5 Management of Elevated LDL-C. Controversy: How Low Should We Go? Controversy: Risks and Benefits of High-Dose Statin Therapy Versus Combination Lipid Drug Therapy. Controversy: Do the Benefits of Low-Density Lipoprotein Cholesterol Reduction Depend Strictly on “How Low You Go” or also on “How You Get There”? Chapter 6 Management of Elevated Triglycerides and Non-High-Density Lipoprotein Cholesterol. 6.1 Clinical Factors Associated with Elevated TG and Non- HDL-C Levels. 6.2 Disorders of TG-Rich Lipoprotein Clearance. 6.3 Insulin Resistance and Hypertriglyceridemia. 6.4 Excessive Production of VLDL: The Primary Lipid Abnormality in the Insulin-Resistant State. 6.5 Reasons for Elevated Free Fatty Acid Levels in Insulin- Resistant States. 6.6 Body Fat Distribution and Insulin Resistance. 6.7 Insulin Resistance in the Nonobese Patient. 6.8 Hypertriglyceridemia and the Development of Atherogenic Dyslipidemia. 6.9 Lifestyle Management for the Metabolic Syndrome and Atherogenic Dyslipidemia. 6.10 Drug Therapies. 6.11 Intensification of Efforts to Lower LDL-C as a Means of Achieving the Non-HDL-C Goal. 6.12 Targeting Triglyceride-Rich Lipoprotein Reduction as a Means of Achieving Non-HDL-C Goal. 6.13 Fibrates. 6.14 Niacin. 6.15 Omega-3 Fatty Acids. 6.16 Management of Diabetic Dyslipidemia. Controversy: Do we Need a Triglyceride Treatment Target to Insure a Predominance of Larger, More Buoyant LDLParticles? Chapter 7 Management of Depressed High-Density Lipoprotein Cholesterol. 7.1 The Relationship between HDL and Risk For CVD. 7.2 Prevalence of Low HDL-C. 7.3 Goals for HDL Treatment. 7.4 Antiatherogenic Effects of HDL. 7.5 HDL and Insulin Resistance. 7.6 Effects of Lifestyle Modification on Serum HDL. 7.7 Pharmacologic Management of Low HDL. Controversy: Do we Need HDL Treatment Goals? Chapter 8 Lipid Management in Population Subsets: Women, the Elderly, Ethnic Minorities, Children, and Adolescents. 8.1 Women. 8.2 Lipids in Women. 8.3 Treatment of Dyslipidemia in Women. 8.4 Sex Hormone Therapy, Lipids, and Cardiovascular Risk in Menopausal Women. 8.5 The Elderly. 8.6 Special Considerations for LipidManagement in the Elderly. 8.7 Ethnic Minorities. 8.8 Risk Factor Incidence and Prevalence in Ethnic Minority Groups. 8.9 Children and Adolescents. Chapter 9 Emerging Risk Factors and Biomarkers of Cardiovascular Disease. 9.1 Role of Inflammation in the Pathogenesis of Atherosclerosis. 9.2 Biomarkers of Cardiovascular Disease. Chapter 10 A Primer on Clinical Trials and Critical Review of Clinical Trial Reports for the Clinician. 10.1 Design Issues Affecting the Validity and Generalizability of Clinical Trial Results. 10.2 Chance, Bias, and Confounding as Potential Explanations for Trial Results. 10.3 Efficacy versus Effectiveness. 10.4 Useful Questions to ask when Evaluating a Published Clinical Trial Report. Chapter 11 Case Studies. Index.

About the Author :
Peter P. Toth, M.D., Ph.D., FAAFP, FICA, FAHA, FACC. Director of Preventive Cardiology, Sterling Rock Falls Clinic, Ltd., Illinois, USA; Chief of Medicine, CGH Medical Center, Illinois, USA; Visiting Clinical Associate Professor, University of Illinois School of Medicine, USA; Editor-in-Chief, Journal of Applied Research?in Clinical and Experimental Therapeutics. Kevin C. Maki, PhD. President, Provident Clinical Research & Consulting, Inc., USA.

Review :
"This is an essential book for physicians who manage patients with lipid disorders. There is no comparable book that provides the depth of information this one does while remaining practical in approach." (Doody's, September 2009)


Best Sellers


Product Details
  • ISBN-13: 9780470056905
  • Publisher: John Wiley & Sons Inc
  • Publisher Imprint: John Wiley & Sons Inc
  • Height: 206 mm
  • No of Pages: 256
  • Returnable: N
  • Sub Title: Concepts and Controversies
  • Width: 135 mm
  • ISBN-10: 0470056908
  • Publisher Date: 10 Oct 2008
  • Binding: Hardback
  • Language: English
  • Returnable: N
  • Spine Width: 20 mm
  • Weight: 363 gr


Similar Products

Add Photo
Add Photo

Customer Reviews

REVIEWS      0     
Click Here To Be The First to Review this Product
Practical Lipid Management: Concepts and Controversies
John Wiley & Sons Inc -
Practical Lipid Management: Concepts and Controversies
Writing guidlines
We want to publish your review, so please:
  • keep your review on the product. Review's that defame author's character will be rejected.
  • Keep your review focused on the product.
  • Avoid writing about customer service. contact us instead if you have issue requiring immediate attention.
  • Refrain from mentioning competitors or the specific price you paid for the product.
  • Do not include any personally identifiable information, such as full names.

Practical Lipid Management: Concepts and Controversies

Required fields are marked with *

Review Title*
Review
    Add Photo Add up to 6 photos
    Would you recommend this product to a friend?
    Tag this Book Read more
    Does your review contain spoilers?
    What type of reader best describes you?
    I agree to the terms & conditions
    You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.

    CUSTOMER RATINGS AND REVIEWS AND QUESTIONS AND ANSWERS TERMS OF USE

    These Terms of Use govern your conduct associated with the Customer Ratings and Reviews and/or Questions and Answers service offered by Bookswagon (the "CRR Service").


    By submitting any content to Bookswagon, you guarantee that:
    • You are the sole author and owner of the intellectual property rights in the content;
    • All "moral rights" that you may have in such content have been voluntarily waived by you;
    • All content that you post is accurate;
    • You are at least 13 years old;
    • Use of the content you supply does not violate these Terms of Use and will not cause injury to any person or entity.
    You further agree that you may not submit any content:
    • That is known by you to be false, inaccurate or misleading;
    • That infringes any third party's copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy;
    • That violates any law, statute, ordinance or regulation (including, but not limited to, those governing, consumer protection, unfair competition, anti-discrimination or false advertising);
    • That is, or may reasonably be considered to be, defamatory, libelous, hateful, racially or religiously biased or offensive, unlawfully threatening or unlawfully harassing to any individual, partnership or corporation;
    • For which you were compensated or granted any consideration by any unapproved third party;
    • That includes any information that references other websites, addresses, email addresses, contact information or phone numbers;
    • That contains any computer viruses, worms or other potentially damaging computer programs or files.
    You agree to indemnify and hold Bookswagon (and its officers, directors, agents, subsidiaries, joint ventures, employees and third-party service providers, including but not limited to Bazaarvoice, Inc.), harmless from all claims, demands, and damages (actual and consequential) of every kind and nature, known and unknown including reasonable attorneys' fees, arising out of a breach of your representations and warranties set forth above, or your violation of any law or the rights of a third party.


    For any content that you submit, you grant Bookswagon a perpetual, irrevocable, royalty-free, transferable right and license to use, copy, modify, delete in its entirety, adapt, publish, translate, create derivative works from and/or sell, transfer, and/or distribute such content and/or incorporate such content into any form, medium or technology throughout the world without compensation to you. Additionally,  Bookswagon may transfer or share any personal information that you submit with its third-party service providers, including but not limited to Bazaarvoice, Inc. in accordance with  Privacy Policy


    All content that you submit may be used at Bookswagon's sole discretion. Bookswagon reserves the right to change, condense, withhold publication, remove or delete any content on Bookswagon's website that Bookswagon deems, in its sole discretion, to violate the content guidelines or any other provision of these Terms of Use.  Bookswagon does not guarantee that you will have any recourse through Bookswagon to edit or delete any content you have submitted. Ratings and written comments are generally posted within two to four business days. However, Bookswagon reserves the right to remove or to refuse to post any submission to the extent authorized by law. You acknowledge that you, not Bookswagon, are responsible for the contents of your submission. None of the content that you submit shall be subject to any obligation of confidence on the part of Bookswagon, its agents, subsidiaries, affiliates, partners or third party service providers (including but not limited to Bazaarvoice, Inc.)and their respective directors, officers and employees.

    Accept

    New Arrivals


    Inspired by your browsing history


    Your review has been submitted!

    You've already reviewed this product!